Regulation of male sex hormone levels by soy isoflavones in rats

Nutrition and Cancer

Volumn 42, Issue 2, 2002, Pages 206-210

  Yi, Mi Ae ^b   Son, Hyun M ^b   Lee, Jung Soon ^a   Kwon, Chong Suk ^c   Lim, Jin Kyu ^a   Yeo, Young Keun ^a   Park, Young Sik ^a   Kim, Jong Sang ^a  

^a Kyungpook National University   (South Korea)

^b Inje University   (South Korea)

^c Andong National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; ISOFLAVONE; SEX HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CANCER GROWTH; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; FOOD INTAKE; GENETIC PREDISPOSITION; GROWTH INHIBITION; HORMONAL REGULATION; NONHUMAN; PROSTATE CANCER; RAT; SOYBEAN;

ANIMALS; DIHYDROTESTOSTERONE; ISOFLAVONES; MALE; RATS; RATS, SPRAGUE-DAWLEY; SOYBEANS;

ANIMALIA; GLYCINE MAX;

EID: 0036032716     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC422_9     Document Type: Article

References (26)

1. Moyad MA: Soy, disease prevention, and prostate cancer. Semin Urol Oncol 17, 97-102, 1999.
2. Lee C, Lee ES, Choi H, Koh SK, Lee JM, et al.: Incidence estimation of genitourinary cancer in Korea. J Kor Med Sci 7, 154-161, 1992.
3. Morton MS, Chan PS, Cheng C, Blacklock N, Matos-Ferreira A, et al.: Lignans and isoflavonoids in plasma and prostatic fluid in men: Samples from Portugal, Hong Kong, and the United Kingdom. Prostate 32, 122-128, 1997.
4. Wakai K, Egami I, Kato K, Kawamura T, Tamakoshi A, et al.: Dietary intake and sources of isoflavones among Japanese. Nutr Cancer 33, 139-145, 1999.
5. Bingham SA, Atkinson C, Liggins J, Bluck L, and Coward A: Phytoestrogens: Where are we now? Br J Nutr 79, 393-406, 1998.
6. Sharma OP, Adlercreutz H, Strandberg JD, Zirkin BR, Coffey DS, et al.: Soy of dietary source plays a preventive role against the pathogenesis of prostatitis in rats. J Steroid Biochem Mol Biol 43, 557-564, 1992.
7. Pylkkanen L, Makela S, and Santti R: Animal models for the preneoplastic lesions of the prostate. Eur Urol 30, 243-248, 1996.
8. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, et al.: Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 129, 1628-1635, 1999.
9. Evans BA, Griffiths K, and Morton MS: Inhibition of 5α-reductase in genital skin fibroblasts and tissue by dietary lignans and isoflavonoids. J Endocrinol 147, 295-302, 1995.
10. Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, et al.: A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 61, 4315-4319, 2001.
11. Wang G, Kuan SS, Fransis OJ, Ware GM, and Carman: A simplified HPLC method for the determination of phytoestrogens in soybean and its processed products. J Agric Food Chem 38, 185-190, 1990.
12. King RA, Broadbent JL, and Head RJ: Absorption and excretion of the soy isoflavone genistein in rats. J Nutr 126, 176-182, 1996.
13. Record IR, Jannes M, Dreosti IE, and King PA: Induction of micronucleus formation in mouse splenocytes by the soy isoflavone genistein in vitro but not in vivo. Food Chem Toxicol 33, 919-922, 1995.
14. Pollard M: Prevention of prostate-related cancers in Lobund-Wistar rats. Prostate 39, 305-309, 1999.
15. Pollard M, Wolter W, and Sun L: Prevention of induced prostate-related cancer by soy protein isolate/isoflavone-supplemented diet in Lobund-Wistar rats. In Vivo 14, 389-392, 2000.
16. Griffiths K, Eaton CL, Harper ME, Peeling B, and Davies P: Steroid hormones and the pathogenesis of benign prostatic hyperplasia. Eur Urol 20 Suppl 1, 68-77, 1991.
17. Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, et al.: 5α-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 339, 887-889, 1992.
18. Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hamalainen E, et al.: Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 54, 1093-1100, 1991.
19. Oesterling JE, Kumamoto Y, Tsukamoto T, Girman CJ, Guess HA, et al.: Serum prostate-specific antigen in a community-based population of healthy Japanese men: Lower values than for similarly aged white men. Br J Urol 75, 347-353, 1995.
20. Geller J, Sionit L, Partido C, Li L, Tan X, et al.: Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. Prostate 34, 75-79, 1998.
21. Linassier C, Pierre M, Le Pecq JB, and Pierre J: Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem Pharmacol 39, 187-193, 1990.
22. Nishimura J, Huang JS, and Deuel TF: Platelet-derived growth factor stimulates tyrosine-specific protein kinase activity in Swiss mouse 3T3 cell membranes. Proc Natl Acad Sci USA 79, 4303-4307, 1982.
23. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, et al.: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262, 5592-5595, 1987.
24. 1-integrin. Clin Exp Metastasis 14, 389-398, 1996.
25. 6-integrins. J Cell Sci 108 Pt 3, 1165-1174, 1995.
26. Kyle E, Neckers L, Takimoto C, Curt G, and Bergan R: Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol Pharmacol 51, 193-200, 1997.